To determine the clinical relevance of elevated KLB expression in HCC patients, we correlated the clinicopathological features between patients with upregulated (> 2-fold) and down-regulated (0.5-fold) KLB mRNA in the respective HCC tissues. The gene discussed is KLB; the disease is hepatocellular carcinoma.